0001006045-26-000001.txt : 20260403 0001006045-26-000001.hdr.sgml : 20260403 20260403144225 ACCESSION NUMBER: 0001006045-26-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260403 DATE AS OF CHANGE: 20260403 EFFECTIVENESS DATE: 20260403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IRIDEX CORP CENTRAL INDEX KEY: 0001006045 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 770210467 STATE OF INCORPORATION: DE FISCAL YEAR END: 0103 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-542889 FILM NUMBER: 26837729 BUSINESS ADDRESS: STREET 1: 1212 TERRA BELLA AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509404700 MAIL ADDRESS: STREET 1: 1212 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 D/A 1 primary_doc.xml X0708 D/A LIVE 0001006045 IRIDEX CORP 1212 TERRA BELLA AVE MOUNTAIN VIEW CA CALIFORNIA 94043 6509404700 DELAWARE Trilogy Medical Systems, Inc. None Corporation true Patrick Mercer c/o IRIDEX Corporation 1212 Terra Bella Avenue Mountain View CA CALIFORNIA 94043 Executive Officer Director Romeo Dizon c/o IRIDEX Corporation 1212 Terra Bella Avenue Mountain View CA CALIFORNIA 94043 Executive Officer Yu-Hao Chen c/o IRIDEX Corporation 1212 Terra Bella Avenue Mountain View CA CALIFORNIA 94043 Director Beverly Huss c/o IRIDEX Corporation 1212 Terra Bella Avenue Mountain View CA CALIFORNIA 94043 Director William Moore c/o IRIDEX Corporation 1212 Terra Bella Avenue Mountain View CA CALIFORNIA 94043 Director Scott Shuda c/o IRIDEX Corporation 1212 Terra Bella Avenue Mountain View CA CALIFORNIA 94043 Director Other Health Care Decline to Disclose 06b true 0001415889-25-009895 2025-03-19 true true true true false 0 20000000 10000000 10000000 This filing is an annual amendment and no additional promissory notes have been issued since the date of first sale; however, the investor will have the right to purchase additional promissory notes in an aggregate principal amount of up to $10,000,000. false 1 0 0 0 false IRIDEX CORP /s/ Patrick Mercer Patrick Mercer President and Chief Executive Officer 2026-04-03